The Science of Cancer Health Equity for Sexual and Gender Minority Communities

性和性别少数群体的癌症健康公平科学

• 批准号: 10749970
• 负责人: Charles Stewart Kamen
• 金额: $ 3.25万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-22 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10749970
• 关键词: Address; American Cancer Society; Area; Attention; Award; Awareness; Back; Cancer Center; Cancer Control; Cancer Patient; Cancer Science; Cancer Survivorship; Cancer health equity; Caregivers; Collaborations; Communities; Community Actions; Complex; Consensus; Data; Data Collection; Diagnosis; Disparity; Epidemiology; Fees; Funding; Future; Gender Identity; Geography; Health; Individual; Infrastructure; Intervention; Lesbian Gay Bisexual Transgender; Lesbian Gay Bisexual Transgender Intersex; Level of Evidence; Los Angeles; Malignant Neoplasms; Medical center; Mentorship; Minority; Modeling; Modification; Names; National Cancer Institute; National Institute on Minority Health and Health Disparities; New York; New York City; Participant; Patients; Peer Review; Persons; Policies; Population; Populations at Risk; Professional Organizations; Publications; Recording of previous events; Research; Research Methodology; Research Personnel; Research Priority; Risk Factors; Safety; Science; Scientist; Screening for cancer; Sex Orientation; Sexual and Gender Minorities; Structure; Survivors; Techniques; Training; Travel; United States National Institutes of Health; Universities; Work; anticancer research; cancer diagnosis; cancer health disparity; cancer prevention; cancer risk; community engagement; community organizations; cost; disparity reduction; experience; gender minority community; gender minority group; innovation; interest; intersectionality; lifetime risk; meetings; member; minority stress; novel; novel strategies; posters; social; symposium; transgender; Address; American Cancer Society; Area; Attention; Award; Awareness; Back; Cancer Center; Cancer Control; Cancer Patient; Cancer Science; Cancer Survivorship; Cancer health equity; Caregivers; Collaborations; Communities; Community Actions; Complex; Consensus; Data; Data Collection; Diagnosis; Disparity; Epidemiology; Fees; Funding; Future; Gender Identity; Geography; Health; Individual; Infrastructure; Intervention; Lesbian Gay Bisexual Transgender; Lesbian Gay Bisexual Transgender Intersex; Level of Evidence; Los Angeles; Malignant Neoplasms; Medical center; Mentorship; Minority; Modeling; Modification; Names; National Cancer Institute; National Institute on Minority Health and Health Disparities; New York; New York City; Participant; Patients; Peer Review; Persons; Policies; Population; Populations at Risk; Professional Organizations; Publications; Recording of previous events; Research; Research Methodology; Research Personnel; Research Priority; Risk Factors; Safety; Science; Scientist; Screening for cancer; Sex Orientation; Sexual and Gender Minorities; Structure; Survivors; Techniques; Training; Travel; United States National Institutes of Health; Universities; Work; anticancer research; cancer diagnosis; cancer health disparity; cancer prevention; cancer risk; community engagement; community organizations; cost; disparity reduction; experience; gender minority community; gender minority group; innovation; interest; intersectionality; lifetime risk; meetings; member; minority stress; novel; novel strategies; posters; social; symposium; transgender

ABSTRACT Sexual and gender minority people (SGM) experience multiple cancer-related disparities, including higher rates of cancer risk factors, lower rates of cancer screening, higher lifetime risk of cancer, and unmet needs during cancer survivorship. Although many national organizations, including the National Cancer Institute (NCI) and the American Cancer Society (ACS), have stated the need for more cancer research among SGM communities, there is currently no consensus about the highest research priorities, promising research models, or mechanisms for collaboration between geographically dispersed scientific teams. To address this gap, we propose a two-and- a-half day conference focused on the “Science of Cancer Health Equity for SGM Communities.” This conference will bring together researchers, trainees, early-stage investigators, and community stakeholders to review the current science on cancer health equity for SGM persons, identify high-priority research topics, and develop novel approaches to engage communities and influence policy. The conference will be held at the New York University (NYU) Langone Medical Center Campus in New York City from October 5-7, 2023. It is structured around a transdisciplinary framework: looking within, across, and between areas of scientific expertise and community wisdom to establish priorities. In line with this framework, we have convened a conference organizing committee comprising two MPIs, representatives from 7 cancer centers, and a SGM Community Action Board, with strong support from SGM community organizations such as the National LGBT Cancer Network. Support from the NCI R13 mechanism (PA-21-151) is needed to cover speaker fees as well as travel costs for trainees, early-stage investigators, patients and community participants. The aims of this conference are: 1) to examine the current level of evidence informing research across the cancer control continuum for SGM cancer patients, survivors, and caregivers; 2) to establish future research priorities across the cancer control continuum for SGM cancer patients, survivors, and caregivers; 3) to promote the research of trainees and early stage investigators, especially those from minoritized backgrounds, interested in research across the cancer control continuum for SGM communities; 4) to develop a transdisciplinary network of scholars with a focus on mentorship and on shared research methods that can address cancer health equity across the cancer control continuum; 5) to disseminate findings from this conference, including priorities for future SGM cancer health equity research, through a publicly available executive summary and a peer-reviewed, open access publication. If funded, this conference will produce: (a) a publicized list of SGM cancer health equity research priorities and (b) a network of transdisciplinary researchers and community members ready to collaborate on projects addressing these priorities. This R13 award will also help us create an infrastructure for future conferences to continue this work, with the next hosted by Cedars Sinai in Los Angeles in 2024.

抽象的 性和性别少数民族（SGM）经历了多种与癌症相关的差异，包括更高的差异 癌症危险因素，较低的癌症筛查率，较高的终身癌症风险以及未满足的需求 癌症生存。尽管许多国家组织，包括国家癌症研究所（NCI）和 美国癌症协会（ACS）表示需要在SGM社区中进行更多的癌症研究， 目前，关于最高的研究重点，有希望的研究模型或机制尚无共识 用于地理分散的科学团队之间的合作。为了解决这一差距，我们提出了两个和两个 A-Half Day会议的重点是“ SGM社区的癌症健康公平科学”。这 会议将将研究人员，学员，早期调查人员和社区利益相关者汇集在一起 回顾当前有关SGM癌症健康公平科学的科学，确定高优先研究主题，并 开发新颖的方法来吸引社区并影响政策。会议将在新的 约克大学（纽约大学）纽约市的Langone Medical Center Campus于2023年10月5日至7日。它是结构化的 围绕跨学科的框架：在科学专业知识和科学专业领域之间，遍布跨学科的框架和 建立优先事项的社区智慧。根据这个框架，我们召集了一次会议组织 委员会完成了两个MPI，代表7个癌症中心和一个SGM社区行动委员会， 在SGM社区组织（例如国家LGBT癌症网络）的大力支持下。 需要提供NCI R13机制（PA-21-151）的支持来支付扬声器供稿和旅行费用 适用于学员，早期的调查人员，患者和社区参与者。这次会议的目的 是：1）检查当前的证据水平，以告知整个癌症控制连续性的研究 SGM癌症患者，生存和看护人； 2）在癌症中确立未来的研究优先事项 SGM癌症患者，生存和护理人员的控制连续性； 3）促进对学员的研究 以及早期的调查人员，尤其是来自少数背景的调查人员，对研究的研究感兴趣 SGM社区的癌症控制连续性； 4）建立学者的跨学科网络 专注于精神训练和共同的研究方法，可以解决整个癌症健康公平 癌症控制继续； 5）传播这次会议的发现，包括未来SGM的优先事项 癌症健康公平研究通过公开可用的执行摘要和同行评审的开放 访问出版物。如果资助，该会议将产生：（a）SGM癌症健康公平清单 研究优先事项以及（b）跨学科研究人员和社区成员的网络 合作解决这些优先事项的项目。该R13奖也将帮助我们创建基础架构 为了使未来的会议继续这项工作，下一个由Cedars Sinai于2024年在洛杉矶举办的。